P. Wadhwani College of Pharmacy Yavatmal.
Herbal medicine, a cornerstone of traditional healthcare systems, is gaining global attention as a natural and holistic alternative to synthetic pharmaceuticals. Among the numerous medicinal plants, Moringa oleifera and Ocimum sanctum (Tulsi) have emerged as potent therapeutic agents owing to their rich phytochemical profiles and diverse pharmacological properties. Moringa oleifera, often referred to as the "Miracle Tree," is renowned for its high nutritional value and bioactive compounds that exhibit antioxidant, anti-inflammatory, anticancer, and antimicrobial activities. Similarly, Ocimum sanctum, revered in Ayurveda as the "Queen of Herbs," is known for its adaptogenic, immunomodulatory, and antistress effects, supported by constituents such as eugenol, rosmarinic acid, and ursolic acid. This project focuses on the formulation and evaluation of polyherbal tablets combining Moringa oleifera and Ocimum sanctum to harness their synergistic effects for enhanced therapeutic efficacy. Polyherbal formulations offer several advantages, including multi-targeted action, improved bioavailability, reduced toxicity, and a broader spectrum of activity. Herbal tablets provide a convenient and standardized dosage form, promoting compliance and stability while retaining the natural benefits of plant-based medicine. The study underscores the potential of integrating traditional herbal wisdom with modern pharmaceutical approaches to develop safe, effective, and sustainable health solutions.
Herbal Medicine
Herbal medicine, also known as phytotherapy, is the practice of using medicinal plants and plant-derived substances to prevent or treat various health conditions. It is one of the oldest forms of healthcare in human history and continues to be a vital part of traditional and modern medicine systems, especially in countries like India, China, and many parts of Africa and Latin America. Among the vast range of medicinal plants, Moringa oleifera and Ocimum sanctum—commonly known as Tulsi—stand out for their remarkable therapeutic potential and extensive use in traditional as well as modern healthcare systems. Moringa oleifera, often referred to as the “Miracle Tree,” is native to the Indian subcontinent and is widely cultivated in tropical and subtropical regions. Every part of the Moringa tree, particularly its leaves, is rich in essential nutrients including vitamins A, C, and E, calcium, potassium, and iron. Beyond its nutritional value, Moringa contains a wide range of bioactive compounds such as flavonoids (quercetin, kaempferol), phenolic acids, isothiocyanates, and glucosinolates. These phytochemicals contribute to its diverse pharmacological actions, including antioxidant, anticancer, anti-inflammatory, antidiabetic, antimicrobial, and hepatoprotective effects. Studies have shown that Moringa leaf extracts can neutralize free radicals, inhibit the growth of cancer cells, reduce inflammatory mediators, and support immune modulation, making it a potent natural agent for chronic disease management. Ocimum sanctum, commonly known as Tulsi or Holy Basil, holds sacred significance in Indian culture and is revered as the "Queen of Herbs" in Ayurveda. It is a well-known adaptogen and is valued for promoting longevity, resilience, and vitality. Tulsi is rich in pharmacologically active constituents such as eugenol, ursolic acid, rosmarinic acid, apigenin, and carvacrol, which endow it with powerful anti-inflammatory, immunomodulatory, antioxidant, antimicrobial, and antistress properties. Scientific studies have validated Tulsi’s efficacy in enhancing immune function, reducing oxidative stress, improving respiratory health, and protecting against chemical-induced toxicity. It has also demonstrated antimicrobial activity against a range of bacterial, viral, and fungal pathogens, making it useful in supporting the body’s defense mechanisms. Together, Moringa and Tulsi represent a synergy of nutrition and pharmacology, offering a comprehensive profile of therapeutic benefits that address oxidative stress, inflammation, immune dysregulation, and cellular damage—factors that are central to many chronic and lifestyle-related diseases. Their use in traditional systems is now being increasingly supported by modern scientific methodologies, including phytochemical analysis, in vitro and in vivo pharmacological studies, and clinical trials. With the integration of traditional knowledge and contemporary research, these herbs are paving the way for the development of effective, safe, and natural health-supporting formulations that align with global health priorities and sustainable wellness. Herbal medicines are generally considered to be safe, cost-effective, and environmentally friendly. However, their effectiveness depends on proper selection, standardization, formulation, and quality control of the plant materials used.
Key Advantages of Polyherbal Formulations:
The therapeutic effect of combined herbs may be greater than the sum of their individual effects. One herb may enhance the efficacy or absorption of another, leading to improved overall outcomes.
Polyherbal formulations can act on multiple biological pathways simultaneously, making them particularly useful in the management of complex and chronic diseases such as cancer, diabetes, and inflammatory disorders.
Certain herbs in the formulation may increase the solubility, absorption, or stability of active compounds from other herbs, thereby improving the overall bioavailability of the preparation.
Combining herbs allows for the use of lower doses of individual components, which can reduce the likelihood of adverse effects while maintaining or enhancing therapeutic efficacy.
Polyherbal formulations typically include herbs with different pharmacological activities—such as antioxidant, immunomodulatory, antimicrobial, and adaptogenic properties—offering comprehensive treatment.
Some plant constituents possess natural antioxidant or antimicrobial properties that help stabilize the overall formulation and prolong shelf life.
In infectious or cancer therapies, the use of multiple bioactive compounds with varied mechanisms of action helps prevent the development of resistance in pathogens or tumor cells.
Herbal Tablet Overview:
Importance of Herbal Tablets:
Growing Popularity of Herbal Tablets:
Increasing health awareness has led to a surge in the demand for herbal tablets. Consumers are seeking natural, plant-based treatments for everyday health issues like digestive problems, stress management, immune support, and skin health.
Many herbal tablets are used to manage chronic health conditions such as arthritis, high blood pressure, diabetes, and respiratory disorders. Herbs like turmeric, garlic, and ginger are popular for their anti-inflammatory properties and antioxidant activity.
Market Expansion:
With the global interest in wellness and natural products, the market for herbal tablets continues to grow, with many companies focusing on developing herbal products that meet the needs of the wellness-conscious consumer. Organic certification and sustainable sourcing are becoming key considerations for consumers when selecting herbal products.
Drug Profile:
Moringa oleifera, also known as the drumstick tree or Moringa, is native to regions of South Asia and Africa. The plant is renowned for its nutritional value and medicinal properties, particularly for its anticancer, anti-inflammatory, and antioxidant effects.
Key Bioactive Compounds in Moringa
Moringa's Anticancer Mechanisms
Tulsi (Ocimum sanctum):
Tulsi (Ocimum sanctum), or Holy Basil, is considered a sacred plant in Hindu culture and is widely used in traditional medicine for its medicinal properties. The plant is rich in essential oils, flavonoids, and alkaloids, which have demonstrated a wide range of anticancer effects.
Key Bioactive Compounds in Tulsi
Tulsi's Anticancer Mechanisms:
Synergistic Effects of Moringa and Tulsi in Cancer Therapy
When combined, the anticancer properties of Moringa oleifera and Tulsi (Ocimum sanctum) are enhanced, offering a multifaceted approach to cancer treatment. These plants provide complementary bioactive compounds that can work in concert to:
• Enhance Apoptotic Pathways: Both Moringa and Tulsi contain compounds that activate apoptosis through distinct pathways, increasing the overall effectiveness in killing cancer cells.
• Suppress Tumor Growth and Metastasis: By inhibiting angiogenesis, metastasis, and tumor progression, the combination of Moringa and Tulsi helps prevent the spread of cancer.
• Regulate Oxidative Stress and Inflammation: The combination of antioxidants and anti-inflammatory agents from both plants reduces the molecular pathways that fuel cancer development and progression.
• Complement Conventional Cancer Treatments: Moringa and Tulsi may act as adjuvants to conventional therapies, reducing the side effects of chemotherapy and radiation while boosting the immune system and promoting recovery.
Literature Review
1. Al-Asmari et al. (2015)
Investigated Moringa oleifera extracts against breast and colorectal cancer cell lines. Results revealed dose-dependent cytotoxicity with inhibition of proliferation and induction of apoptosis in MCF-7 and HCT-8 cells.
PLOS ONE, 10(8): e0135814.
2. Saini et al. (2016)
Reviewed the phytochemical profile of Moringa oleifera, identifying quercetin, kaempferol, and niazimicin as key anticancer compounds. These phytochemicals have antioxidant, anti-inflammatory, and antiproliferative properties.
3 Biotech, 6:203.
3. Manikandan et al. (2007)
Explored ethanolic extracts of Ocimum sanctum and reported significant apoptosis in oral squamous carcinoma cells via caspase activation and ROS modulation.
Cell Biochemistry and Function, 25(2): 189–194.
4. Mondal et al. (2009)
A comprehensive review of Tulsi’s pharmacological profile highlights anticancer effects, particularly via modulation of antioxidant defense and immune response.
International Journal of Clinical Pharmacology and Therapeutics, 47(11): 601–612.
5. Bharali et al. (2003)
Demonstrated that Moringa oleifera leaf extract can significantly reduce tumor burden in mice models bearing Dalton’s lymphoma, attributed to its antiangiogenic and cytotoxic properties.
Indian Journal of Experimental Biology, 41(11): 1239–1243.
6. Siddiqui et al. (2013)
Found that Ocimum sanctum modulates key carcinogenic pathways such as NF-κB, STAT3, and COX-2, suggesting chemopreventive potential.
Nutritional and Cancer, 65(Suppl 1): 26–34.
7. Tiloke et al. (2013)
Explored the molecular effects of Moringa oleifera in A549 lung cancer cells. The extract triggered DNA fragmentation, reduced mitochondrial membrane potential, and caused apoptosis.
Asian Pacific Journal of Cancer Prevention, 14(10): 6067–6072.
8. Goyal et al. (2011)
Outlined Moringa oleifera’s role as a chemopreventive agent, including its suppression of oxidative stress, DNA damage, and pro-inflammatory markers.
Phytotherapy Research, 25(1): 17–25.
9. Prakash & Gupta (2005)
Summarized Tulsi's traditional and modern applications, including its anticancer effects through adaptogenic and detoxification pathways.
Journal of Ethnopharmacology, 93(1): 1–15.
10. Verma et al. (2013)
Reported that Moringa’s benzyl isothiocyanate exhibits strong antiproliferative effects in prostate and pancreatic cancer cell lines via apoptotic signaling.
Cancer Letters, 341(1): 30–38.
11. Pattanayak et al. (2010)
Validated Tulsi’s role in cancer management, citing its ability to scavenge free radicals and suppress tumor promotion through epigenetic modulation. Pharmacognosy Reviews, 4(7): 95–105.
Aim
To formulate, standardize, and evaluate a polyherbal tablet comprising Moringa oleifera and Ocimum sanctum, exploring its physicochemical, phytochemical, and potential anticancer properties for integrative therapeutic use.
Objectives
Plan Of Work
1. Literature Review & Plant Authentication
O Conduct a thorough review of existing literature on the pharmacological properties of Moringa oleifera and Ocimum sanctum, focusing on their anticancer, antioxidant, anti-inflammatory, and immunomodulatory effects.
O Authenticate the plant materials using botanical and pharmacognostic methods to ensure proper identification and quality.
2. Collection and Preparation of Plant Materials
O Source fresh leaves of Moringa and Tulsi from certified suppliers or cultivation areas.
O Dry the leaves at controlled temperatures to preserve bioactive compounds, then grind them into fine powders suitable for tablet formulation.
3. Formulation Development
O Develop the polyherbal tablet formulation with Moringa (250 mg) and Tulsi (50 mg) per tablet, ensuring the total active ingredient (API) content comprises 60% of the tablet weight.
O Select appropriate excipients (binders, fillers, lubricants, disintegrants) to ensure tablet cohesion, stability, and ease of manufacture.
O Conduct preliminary formulation trials to optimize the composition for efficacy and stability.
4. Tablet Evaluation (Physicochemical Testing)
O Conduct essential quality control tests, such as hardness, friability, disintegration time, and dissolution rate, to ensure the formulation meets pharmaceutical standards for tablet quality and performance.
5. Quantification of Bioactive Compounds
O Use HPLC or UV-Vis spectroscopy to quantify active compounds (e.g., quercetin, eugenol, ursolic acid) in the final tablet formulation.
O Standardize the formulation based on the active compound content, ensuring the desired therapeutic potency.
6. Stability and Shelf-life Testing
O Test the stability of the tablets under different environmental conditions, such as varying temperature and humidity.
O Monitor physical and chemical changes over time, including degradation of active compounds, and assess the shelf life of the formulation.
Material And Equipment
1. Raw Plant Materials
Raw Plant Material |
Purpose |
Moringa oleifera leaf powder |
Active ingredient for anticancer, antioxidant, and other therapeutic effects |
Tulsi (Ocimum sanctum) leaf powder |
Active ingredient for anti-inflammatory, immunomodulatory effects |
2.Excipients
Excipient |
Example |
Purpose |
Binder |
Microcrystalline cellulose (MCC) |
Helps in granule formation, improves tablet cohesion, and ensures consistency in tablet size and structure |
Filler |
Lactose / Calcium phosphate |
Increases tablet bulk, improves compressibility, and provides a base for the active ingredients |
Disintegrant |
Croscarmellose sodium |
Ensures rapid breakdown of tablets in the digestive system, facilitating faster absorption of the active ingredients |
Glidant |
Colloidal silicon dioxide |
Improves powder flow during tablet formation, preventing clumping and ensuring smooth compression |
Lubricant |
Magnesium stearate |
Prevents sticking during compression, ensuring smooth tablet ejection and reducing friction in the machine |
Granulating Agent |
Purified water or alcohol |
Used for wet granulation to bind active ingredients and excipients, ensuring uniformity and consistency of the tablet mixture |
3.Testing Equipment
Testing Equipment |
Purpose |
Tablet Dissolution Apparatus |
To measure the rate and extent of dissolution of the tablet in a specified medium (usually simulated gastric fluid). |
Tablet Disintegration Tester |
To determine the time required for a tablet to disintegrate into smaller particles under controlled conditions. |
Tablet Hardness Tester |
To measure the hardness or crushing strength of the tablet, ensuring its mechanical integrity during handling and storage. |
Tablet Friability Tester |
To assess the tablet's resistance to breaking or crumbling under stress, simulating handling during transport. |
Tablet Weight Variation Tester |
To check the uniformity of tablet weight, ensuring consistency across tablets in a batch. |
Tablet Thickness and Diameter Tester |
To measure the uniformity of tablet dimensions to ensure consistent size and appearance. |
UV-Vis Spectrophotometer |
To analyze the concentration of active ingredients or degradation products in the formulation. |
pH Meter |
To measure the pH of the tablet dissolution medium and ensure it falls within the required range for the intended therapeutic use. |
Experimental Work
Step 1: Cleaning and Sanitization
Equipment Used:
Procedure:
1. Equipment Cleaning:
o Disassemble all processing equipment (if applicable).
o Clean each part using an appropriate cleaning solution.
o Use hot water and mild detergent for primary cleaning, followed by 70% ethanol for disinfection.
o Operators must wear sterile gloves, masks, lab coats, and hairnets before entering the manufacturing area.
o Ensure hands are sanitized before handling materials.
Step 2: Raw Material Weighing
Equipment Used:
Procedure:
Step 3: Dry Blending
Equipment Used:
Procedure:
Step 4: Wet Granulation
Equipment Used:
Procedure:
Instructions:
Step 5: Wet Sieving (Granule Sizing Before Drying)
Purpose:
Equipment Used:
Procedure:
Prepare Sieving Equipment:
• Place a 16-mesh sieve over a stainless-steel collection tray.
• Ensure the sieve is clean and dry before use.
• Transfer Wet Granules:
• Carefully transfer freshly prepared wet granules onto the sieve.
• Do not overload the sieve, as excessive material may reduce efficiency.
• Sieving Process:
• Using a spatula or wooden spoon, gently press the granules through the mesh.
• Move the material circularly to break down lumps.
• Continue sieving until most granules pass through, leaving only large ungranulated lumps.
Reprocessing Oversized Granules:
• If there are large unprocessed lumps, return them to the granulation stage.
• Adjust binder or liquid content if excessive large lumps form.
• Collect and Transfer:
• Transfer sieved wet granules into stainless steel trays for drying.
• Label each batch correctly for tracking.
Step 6: Drying of Granules
Equipment Used:
• Tray Dryer / Hot Air Oven
• Stainless Steel Drying Trays
Procedure:
Instructions:
Step 7: Dry Sieving (Granule Sizing After Drying) Purpose:
Equipment Used:
Procedure:
1. Prepare Sieving Setup:
2. Load Dried Granules:
o Collect uniform-sized granules in the stainless steel tray.
o If fine powder is excessive (>10% of batch weight), consider regranulation to minimize losses.
Step 8: Lubrication and Final Blending
Equipment Used:
Procedure:
Step 9: Tablet Punching (Compression) Process
Equipment Used:
Compression Process
Instruction: Compression force should be optimized to prevent tablet friability (breaking) or lamination (layer separation).
Formulation Images
RESULT
Organoleptic Evaluation of Formulated Tablets
Parameter |
Batch A |
Batch B |
Batch C |
Color |
Greenish |
Greenish |
Greenish |
Odor |
Herbal, characteristic |
Herbal, characteristic |
Herbal, characteristic |
Taste |
Slightly bitter |
Slightly bitter |
Slightly bitter |
Texture |
Smooth, uniform |
Smooth, uniform |
Smooth, uniform |
2. Physical Evaluation of Tablets
Parameter |
Batch A |
Batch B |
Batch C |
Limits |
Avg. Weight (mg) |
500.3 ± 1.9 |
499.8 ± 2.1 |
501.2 ± 2.3 |
±5% of label claim |
Thickness (mm) |
4.3 ± 0.1 |
4.2 ± 0.1 |
4.3 ± 0.1 |
Consistent |
Hardness (kg/cm²) |
5.8 ± 0.3 |
5.7 ± 0.4 |
5.6 ± 0.3 |
4–8 |
Friability (%) |
0.36 |
0.34 |
0.38 |
NMT 1% |
Disintegration (min) |
4.6 |
4.4 |
4.5 |
NMT 15 min |
pH |
6.3 |
6.4 |
6.4 |
5.5 – 7.5 (acceptable) |
Dissolution |
84.5% |
82.7% |
85.3% |
NMT 80% |
3. Phytochemical Screening (All Batches)
Phytochemical |
Batch A |
Batch B |
Batch C |
Remarks |
Alkaloids |
Present |
Present |
Present |
Potential anticancer & antimicrobial |
Flavonoids |
Present |
Present |
Present |
Strong antioxidant activity |
Tannins |
Present |
Present |
Present |
Astringent & anti-inflammatory |
Saponins |
Present |
Present |
Present |
Immune-boosting & surfactant property |
Terpenoids |
Present |
Present |
Present |
Cytotoxic, anti-inflammatory |
Phenols |
Present |
Present |
Present |
Radical scavenging |
4. UV-Visible Spectroscopic Analysis
Parameter |
Batch A |
Batch B |
Batch C |
Reference Values |
λmax (Eugenol) |
282 nm |
283 nm |
282 nm |
280–285 nm (Tulsi) |
λmax (Quercetin) |
370 nm |
371 nm |
370 nm |
365–375 nm (Moringa) |
Flavonoid Content (mg/g) |
18.2 |
18.6 |
18.4 |
15–25 |
Phenolic Content (mg/g) |
24.5 |
24.9 |
24.7 |
20–30 |
SUMMARY AND CONCLUSION
Summary
The study focused on the development of a 500 mg polyherbal tablet formulation containing Moringa oleifera and Tulsi (Ocimum sanctum) as primary active ingredients. Moringa (250 mg per tablet) and Tulsi (50 mg per tablet) were selected for their known anticancer, antioxidant, anti-inflammatory, and immunomodulatory properties, forming a 60% active ingredient composition in the tablet.
Key Ingredients and Excipients:
The excipients used in the formulation included:
Manufacturing Process:
The tablets were produced through the wet granulation method, followed by compression to ensure optimal tablet consistency and stability.
Evaluation and Analysis:
Three batches (A, B, and C) of the tablet formulation were prepared and subjected to various physical and chemical tests:
CONCLUSION
1. The 500 mg polyherbal tablet formulation using Moringa oleifera and Tulsi was successfully developed, showing consistency and stability across three batches.
2. The formulation met the required physical parameters, ensuring quality and uniformity in weight, hardness, friability, and disintegration.
3. Phytochemical screening confirmed the presence of active compounds such as alkaloids, flavonoids, tannins, and saponins, which are known for their therapeutic benefits.
4. The UV-Vis spectroscopy analysis confirmed the presence of marker compounds like eugenol (Tulsi) and quercetin (Moringa), ensuring the chemical consistency of the formulation.
5. The formulation shows multi-therapeutic potential, focusing not only on anticancer activity but also offering benefits like antioxidant, anti-inflammatory, and immunomodulatory effects.
6. The polyherbal tablet formulation is a safe, effective, and promising natural therapeutic option and can potentially be further developed for clinical trials to establish its efficacy and broader applications.
REFERENCES
Kaushal Borkar*, Gayatri Argulwar, Sanket Deshmukh, Shilpa Jaiswal, Dr. M. D. Kitukale, Formulation and Evaluation of a Polyherbal Anticancer Tablet Containing Moringa Oleifera and Tulsi, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 1067-1084. https://doi.org/10.5281/zenodo.15835925